Supplementary Tables S1 - S5 from In Vivo Genetic Screens of Patient-Derived Tumors Revealed Unexpected Frailty of the Transformed Phenotype

Supplementary Table S1. Patient Demographics, and Clinical Characteristics of the Metastatic Cutaneous Melanomas and the Patient-derived xenografts (PDXs). Supplementary Table S2. A, Analysis of the epigenetic screening performed in MM13, MM16 and MM27 PDXs. B, Summary of the epigenetic screening results. Supplementary Table S3. List of shRNAs composing the 80sh-library (shRNA ID), sequenced hairpins and associated barcodes, and Log2(ratio) values derived from the screening analysis of MM13, MM16 and MM27 PDXs. Supplementary Table S4. List of the 103 genes specifically de-regulated in the two NRAS-mutated patients. Supplementary Table S5. Values of RNA expression of 52 candidate genes in metastatic melanoma PDXs.